Hypophosphatemia Overview
Learn About Hypophosphatemia
Hypophosphatemia is a low level of phosphorus (phosphate) in the blood.
Low blood phosphate; Phosphate - low; Hyperparathyroidism - low phosphate
The following may cause hypophosphatemia:
- Alcoholism
- Antacids
- Certain medicines, including insulin, acetazolamide, foscarnet, imatinib, intravenous iron, niacin, pentamidine, sorafenib, and tenofovir
- Fanconi syndrome
- Fat malabsorption in the gastrointestinal tract
- Hyperparathyroidism (overactive parathyroid gland)
- Starvation
- Too little vitamin D
Symptoms may include:
- Bone pain
- Confusion
- Muscle weakness
- Seizures
Treatment depends on the cause. Phosphate can be given by mouth or through a vein (IV).
Rahul Prakash, M.D., P.A.
Shalin Patel is a Nephrologist in Katy, Texas. Dr. Patel and is rated as an Advanced provider by MediFind in the treatment of Hypophosphatemia. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Childhood Hypophosphatasia (HPP), and Hypophosphatasia (HPP).
Kelsey-Seybold Medical Group, PLLC
Jalaja Joseph is an Endocrinologist in Richmond, Texas. Dr. Joseph and is rated as an Experienced provider by MediFind in the treatment of Hypophosphatemia. Her top areas of expertise are Newborn Low Blood Sugar, Type 2 Diabetes (T2D), Prolactinoma, and Maturity Onset Diabetes of the Young.
Houston Kidney Specialists Center PLLC
Jonathan Pankow is a Nephrologist in Cypress, Texas. Dr. Pankow and is rated as an Experienced provider by MediFind in the treatment of Hypophosphatemia. His top areas of expertise are Acute Kidney Failure, Necrosis, Low Sodium Level, and High Potassium Level. Dr. Pankow is currently accepting new patients.
How well you do depends on what has caused the condition.
Contact your provider if you have muscle weakness or confusion.
Summary: Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple blood test, rare genetic conditions can be easily detected, and the early start of transformative treatment will help avoid severe disabilities and increase the quality of life. Baby Detect Project is an innovative NBS program using a pane...
Summary: The primary purpose of Study INZ701-106 (The ENERGY 3 Study) is to assess the efficacy and safety of INZ-701 in children with ENPP1 Deficiency.
Published Date: December 31, 2023
Published By: Walead Latif, MD, Nephrologist and Clinical Associate Professor, Rutgers Medical School, Newark, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Chonchol M, Smogorzewski MJ, Stubbs, JR, Yu ASL. Disorders of calcium, magnesium, and phosphate balance. In: Yu ASL, Chertow GM, Luyckx VA, Marsden PA, Skorecki K, Taal MW, eds. Brenner and Rector's The Kidney. 11th ed. Philadelphia, PA: Elsevier; 2020:chap 18.
Klemm KM, Klein MJ, Zhang Y. Biochemical markers of bone metabolism. In: McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Philadelphia, PA: Elsevier; 2022:chap 16.
Yu ASL. Diseases of magnesium and phosphorus. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 105.